The MIT professors collaborated to identify the first AI-discovered antibiotic, a scientific breakthrough that is widely recognized as a milestone in AI-driven drug discovery.
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Read MoreProfessor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Read MoreMIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
Read MoreThe team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
Read More
You must be logged in to post a comment.